Inicio › Cánceres de la sangre › Maryland
Ensayos clínicos de Cánceres de la sangre en Maryland
29 estudios sobre Cánceres de la sangre buscan participantes en Maryland.
Ciudades en Maryland
Texto oficial del estudio (inglés)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 a 110 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05724121Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1
Edades de 18 a 120 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06904066Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- MedStar Franklin Square Medical Center ( Site 0046), Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore
- Maryland Oncology Hematology (MOH) ( Site 8000), Columbia
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- y 10 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
ReclutandoFase 1 temprana
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06398457Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 23, Baltimore
ReclutandoFase 3
Edades de 18 a 71 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 12 a 120 · Todos los sexos · Actualizado el 22 sept 2026 · NCT05470491Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1
Edades de 18 a 75 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07162038Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Johns Hopkins Asthma & Allergy Center, Baltimore
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07648264Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 12 a 120 · Todos los sexos · Actualizado el 18 sept 2026 · NCT05327023Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Christiana Care - Union Hospital, Elkton
- UM Saint Joseph Medical Center, Towson
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 17 sept 2026 · NCT04242095The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 12 a 120 · Todos los sexos · Actualizado el 11 sept 2026 · NCT05436418Longitudinal Studies of Patient With FPDMM
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
1 Day – 100 Years · Todos los sexos · Actualizado el 11 sept 2026 · NCT03854318A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- The Center for Cancer and Blood Disorders, Bethesda
ReclutandoEstudio observacional
Edades de 0 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07154823Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
- John Hopkins University, Baltimore
ReclutandoFase 1 temprana
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06184321Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
- Tania Jain, MD, Baltimore
ReclutandoFase 1
6 Months – 80 Years · Todos los sexos · Actualizado el 14 ago 2026 · NCT02203903PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- Johns Hopkins Hospital, Baltimore
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 ago 2026 · NCT06665100A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Johns Hopkins, Baltimore
- Nih/Niaid, Bethesda
- Nih/Nhlbi, Bethesda
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- The Center for Cancer and Blood Disorders (CCBD), Bethesda
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jun 2026 · NCT04068597Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1/2Se aceptan voluntarios sanos
Edades de 12 a 85 · Todos los sexos · Actualizado el 11 jun 2026 · NCT04959175Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
- University of Maryland, Baltimore, Baltimore
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 jun 2026 · NCT06482515Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 jun 2026 · NCT05663502Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 120 · Todos los sexos · Actualizado el 27 may 2026 · NCT06856226A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
ReclutandoFase 3
Edades de 2 a 18 · Todos los sexos · Actualizado el 5 may 2026 · NCT05711667A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- Johns Hopkins School of Medicine, Baltimore
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT05735184Ocular Complications From Cancer Therapy - Patient Registry and Biobank
- Stoler Outpatient Cancer Center at the University of Maryland, Baltimore
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 mar 2026 · NCT06874283A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
- University of Maryland Medical Center, Baltimore
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 jun 2025 · NCT05768269Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Johns Hopkins University, Baltimore
- National Cancer Institute, Pediatric Oncology Branch, Bethesda
ReclutandoFase 1
Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.